After several puzzling discoveries have proven that certain stem cell populations are not stem cells at all, or that some differentiated adult cells are able to revert to a stem-like state in certain situations, scientists are redefining what it means to be a stem cell. Dr. Hans Clevers, Dr. Jonathan Hoggatt, and Dr. Pamela Robey discuss tissue repair, phony treatments, and the controversy of what characterizes “stemness” in this piece by Jordana Cepelewicz of Quanta Magazine.
Hannah was awarded the prestigious American Society of Hematology “Outstanding Abstract Achievement Award” at the 2015 annual meeting as the top undergraduate abstract presenter.
Photo of Hannah receiving award in ASH News Daily
The Scientist webinar on December 1st, 2015 discussing therapeutic targeting of the stem cell niche.
Jon is currently a Contributing Editor of The Hematologist, a publication of the American Society of Hematology that updates readers about important developments in the field of hematology and highlights what ASH is doing for its members.
Click to view Jon’s Contributions
To hear Jon’s podcast with Nature Medicine discussing his work to enhance bone marrow transplantation, scroll ahead to 23:50 in the podcast link below.
Click For Podcast Via Nature Medicine Podcast
Recent Feature on Nature & Scientific American
Aspirin-like drugs could improve the success of stem-cell transplants for patients with blood or bone-marrow disorders, a study suggests. The compounds coax stem cells from bone marrow into the bloodstream where they can be…